Compound ID | 609

Update compound information

HMR 1043

Class: Lipopeptide

Spectrum of activity: Gram-positive
Mechanism of action: Unknown
Target Pathogen: Active against Staphylococcus aureus
Institute where first reported: Aventis (Sanofi-Aventis, France)
Year first mentioned: 2000
Development status: Experimental
Reason dropped: Antibiotic research closed down by Aventis in 2002
Chemical structure(s):
Click here for structure editor
Molecular weight:
Iso. SMILES: NC(CC(C(NC1C(N2C(C(NC(C(C(O)=O)C)C(NC(CC(O)=O)C(NCC(NC(C(NCC(NC(C(NC(C(N3CCCC3C(NC1C)=O)=O)C(C)C)=O)C(C)N)=O)=O)C(O)=O)=O)=O)=O)=O)CCCC2)=O)=O)NC(C/C=C/CCCCCCCC(C)C)=O)=O
InChI Key: SGPAFVFSVVUNTE-FYWRMAATSA-N
Can. SMILES: CC(C)CCCCCCC/C=C/CC(=O)NC(CC(=O)N)C(=O)NC1C(C)NC(=O)C2CCCN2C(=O)C(C(C)C)NC(=O)C(C(C)N)NC(=O)CNC(=O)C(C(=O)O)NC(=O)CNC(=O)C(CC(=O)O)NC(=O)C(C(C)C(=O)O)NC(=O)C3CCCCN3C1=O
InChI: InChI=1S/C58H92N14O19/c1-29(2)19-14-12-10-8-9-11-13-15-22-39(74)64-34(25-38(60)73)49(80)70-46-33(7)63-50(81)37-21-18-24-72(37)55(86)43(30(3)4)68-54(85)45(32(6)59)66-40(75)28-62-52(83)47(58(90)91)67-41(76)27-61-48(79)35(26-42(77)78)65-53(84)44(31(5)57(88)89)69-51(82)36-20-16-17-23-71(36)56(46)87/h13,15,29-37,43-47H,8-12,14,16-28,59H2,1-7H3,(H2,60,73)(H,61,79)(H,62,83)(H,63,81)(H,64,74)(H,65,84)(H,66,75)(H,67,76)(H,68,85)(H,69,82)(H,70,80)(H,77,78)(H,88,89)(H,90,91)/b15-13+
External links:
Citation: https://doi.org/10.1128/aac.47.9.3025-3029.2003

AntibioticDB is supported by GARDP.

If you have feedback, experience problems, or are interested in a collaboration, please contact us. | Terms and conditions

The content of this site is intended for educational and scientific research purposes only and not as a source of medical advice or consultation.